Back to search

Article

Human Epidermal Growth Factor Receptor-2(HER-2) expression in Sri Lankan gastric adenocarcinoma patients: An analysis of the concordance of HER2 expression and survival based on silver in-situ hybridization (SISH)

2021-03-17

Abstract excerpt

<h4>Background: </h4> Accurate HER2 status is crucial for gastric adenocarcinoma (GC) patient selection for antiHER2 therapy. It is assessed immunohistochemically (IHC) for protein expression, and by silver in-situ hybridization (SISH) for gene copy number. This study aimed to evaluate the concordance of HER2 status by IHC/SISH analyses and HER2-SISH based survival. <h4>Methods: </h4>: This prospective study inclu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
64984a96-35cc-5cb9-b843-e5bff94321f6
DOI
10.21203/rs.3.rs-298497/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Human Epidermal Growth Factor Receptor-2(HER-2) expression in Sri Lankan gastric adenocarcinoma patients: An analysis of the concordance of HER2 expression and survival based on silver in-situ hybridization (SISH)DOI 10.21203/rs.3.rs-298497/v1
Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization methodSemantic proximity
The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testingSemantic proximity
A study of HER2 gene amplification and protein expression in gastric cancerSemantic proximity
Gastric HER2 Testing Study (GaTHER)Semantic proximity
Integrated Evaluation of TRK Expression in Gastric Adenocarcinoma: Correlation with Immunohistochemistry- and In Situ Hybridization–Based Molecular Classification and Diagnostic ChallengesSemantic proximity
Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American PathologistsSemantic proximity
HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteriaSemantic proximity
Concordance analysis between HER2 immunohistochemistry and in situ hybridization in non-small cell lung cancer.Semantic proximity
IMMUNOHISTOCHEMICAL ANALYSIS OF SONIC HEDGEHOG, MUCIN AND HER-2 IN GASTRIC ADENOCARCINOMASemantic proximity
FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohortSemantic proximity
EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagusSemantic proximity
Determination of <i>HER2</i> amplification in primary breast cancer using dual‐colour chromogenic <i>in situ</i> hybridization is comparable to fluorescence <i>in situ</i> hybridization: a European multicentre study involving 168 specimensSemantic proximity
Select a neighboring publication to make it the new centre.